Articles

  • 2 months ago | outsourcedpharma.com | Louis Garguilo |Jessica Carmen |A Focus |GC Cell

    Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and LeadershipClinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success.

  • Oct 28, 2024 | cellandgene.com | Tyler Menichiello |Joonman Hong |GC Cell |WuXi Advanced Therapies

    It's no secret that on-going research aims to improve the efficacy and specificity of non-viral approaches for genetic engineering. But the field is rapidly evolving with research aimed at improving transfection efficiency, targeting, and safety profiles of non-viral delivery systems. Join Cell & Gene Live to discuss the most notable approaches and recent breakthroughs as well as promising non-viral vectors used in clinical trials. Attendance is free thanks to the support of MaxCyte.

  • Oct 22, 2024 | bioprocessonline.com | Joonman Hong |GC Cell |Junwei Sun |Lucia Fernandez |Lucia Fernández

    Establishing Commercial Manufacturing Services For Antibody-Drug ConjugatesA significant portion of ADC projects are outsourced to CDMOs and with the continued expansion of pipelines and more commercial products reaching the market, CDMOs with plans to support commercial-scale ADC manufacturing need to invest in facilities and set up processes to handle complex supply chains and ensure efficiency, quality, and safety.

  • Sep 30, 2024 | cellandgene.com | Irwin Hirsh |Q-Specialists AB |Joonman Hong |GC Cell

    Reserve your space for our Virtual Symposium on October 08! Moderated by Dr. Eleni Samaridou, Principal Scientist, Early Formulation Screening Service at MilliporeSigma, the symposium will feature Dr. Roland Böttger, Senior Scientist at CureVac, and other industry experts.

  • Sep 10, 2024 | fox2now.com | GC Cell

    YONGIN, South Korea, Sept. 10, 2024 /PRNewswire/ -- GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifarma Adiluhung (Bifarma), a premier stem cell therapy company in Indonesia. This strategic partnership, which began in June, solidifies approximately three months later with the signing of the final license agreement.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →